Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 31 n° 301

Posts Tagged ‘takeda’

Takeda to Demonstrate Global Leadership in Hematology at ISTH 2019

Posted by fidest press agency su giovedì, 4 luglio 2019

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”), the global biotechnology leader in rare diseases, will present research covering a broad range of rare bleeding disorders at the 27th Annual International Society on Thrombosis and Haemostasis Congress (ISTH), July 6-10, 2019 in Melbourne, Australia. Showcased in 10 oral presentations and 38 poster presentations, these data underscore Takeda’s pursuit of treatment innovation to achieve optimized and personalized patient care in hematology.
“At Takeda, we are proud of the hematology heritage Shire, Baxalta and Baxter built over 70 years and we plan on expanding on it through continued research and innovation, in pursuit of a world without bleeds,” said Dr. med. Wolfhard Erdlenbruch, Vice President Head of Global Medical Affairs Hematology, Takeda. “We look forward to presenting new data from PROPEL and important updates from our gene therapy and leading factor pipeline at ISTH 2019, showcasing our continued development and commitment in this area.”
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines.Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Gastroenterology (GI), Neuroscience, and Rare Diseases. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Takeda Israel Awarded the Best Place to Work in Israel for 2018

Posted by fidest press agency su mercoledì, 11 aprile 2018

Takeda Israel was recognized as a best place to work in Israel for 2018, according to the annual Workplace program driven by the global research firm BPTW and Best Companies Group USA. Best Places to Work program is an international program providing employers in different regions the opportunity to learn more about the engagement and satisfaction of their employees and honor those who deliver an outstanding work experience. Additionally, The Best Places To Work certification is awarded to organizations where voices are heard, cultures are thriving, and employees are engaged.
Takeda Israel, a Japanese global research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients, received outstanding scores across several aspects of their workplace such as culture, pay and benefits, leadership, opportunities of growth where employees get the right environment to grow to their true potential.“I’m excited and honored to get this important recognition which demonstrates the journey Takeda Israel has gone to become a Best in Class Pharma Provider also from our people perspective,” said Arie Kramer, General Manager for Takeda Israel.“I am proud and inspired by all the great work done leading to this achievement. We are passionate about providing the right environment so our people can shine in their careers,” said Inbal Orbach, HR Director For Takeda Israel.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Quale futuro per la sanità in Italia?

Posted by fidest press agency su mercoledì, 13 ottobre 2010

Roma 19 ottobre 2010 – dalle 9 alle 13 Sala capitolare presso il Chiostro del convento di Santa Maria piazza della minerva 38 Interverranno:Maurizio Castorina Presidente e Amministratore Delegato Takeda Italia Farmaceutici Cesare Catananti Direttore del Policlinico Universitario Gemelli di Roma Maurizio de Cicco Vice Presidente Farmindustria  Nerina Dirindin Docente di Economia Pubblica e di Scienza delle Finanze Università di Torino Ferruccio Fazio*
Ministro della Salute Paolo Mariani Docente di Statistica Economica, Università degli Studi di Milano Bicocca Giovanni Monchiero  Presidente FIASO Giuseppe Palumbo  Presidente Commissione Affari Sociali Camera dei deputati  Maddalena Pelagalli Presidente Coordinamento Nazionale Associazioni Malati Cronici Francesco Ripa di Meana Direttore Generale Ausl di Bologna Daniela Scaramuccia Assessore alla Salute Regione Toscana  Lorenzo Sommella
Direttore Sanitario Azienda Ospedaliera San Filippo Neri di Roma  Federico Spandonaro Esperto di Economia Sanitaria, Docente Università di Tor Vergata di Roma Antonio Tomassini  Presidente XII Commissione Igiene e Sanità, Senato della Repubblica  e Presidente Associazione Parlamentare per la Tutela e la Promozione del Diritto alla Prevenzione  Leonardo ZanardiAmministratore Delegato Quintiles Moderatore: Paolo Del Bufalo, Giornalista, Il Sole 24 ORE Sanità Interventi:
•    Scenario attuale del sistema sanitario: tra criticità e innovazione
•    Realizzazione di attività per e con la sanità pubblica: quali aree di convergenza tra payers ed aziende? Risultati di una recente ricerca
•    l rapporto pubblico-privato in Sanità: confronto  tra il modello teorico e la sua applicazione concreta Esempi di partnership attraverso progetti patient centric
Tavola rotonda L’interazione tra pubblico e privato: sinergie e ruolo dell’outsourcing per migliorare la qualità e l’efficienza del sistema salute

Posted in Cronaca/News, Medicina/Medicine/Health/Science, Roma/about Rome | Contrassegnato da tag: , , , | Leave a Comment »